Junxiang Wang, Kaiyi Li, Yuan Wang, Zhengfang Lin, Weidong Li, Jinpeng Cao, Xinyue Mei, Rui Wei, Jinglu Yang, Xiaobing Zhai, Deyi Huang, Kaiwen Zhou, Xinyue Liang, Zhongfang Wang
UNLABELLED: Limited knowledge is available on the differences in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific antibody breadth and T cell differentiation among different COVID-19 sequential vaccination strategies. In this study, we compared the immunogenicity of the third different dose of COVID-19 vaccines, such as mRNA (I-I-M), adenoviral vector (I-I-A), and recombinant protein (I-I-R) vaccines, in terms of the magnitude and breadth of antibody response and differentiation of SARS-CoV-2-specific T and B cells...
September 9, 2024: MBio